Feng ZH - Search Results

1

Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells.

Zhang S, Li ZT, Liu M, Wang JR, Xu MQ, Li ZY, Duan XC, Hao YL, Zheng XC, Li H, Feng ZH, Zhang X. Zhang S, et al. Among authors: feng zh. J Control Release. 2019 Feb 10;295:102-117. doi: 10.1016/j.jconrel.2018.12.034. Epub 2018 Dec 21. J Control Release. 2019. PMID: 30582952

2

Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo.

Duan XC, Yao X, Zhang S, Xu MQ, Hao YL, Li ZT, Zheng XC, Liu M, Li ZY, Li H, Wang JR, Feng ZH, Zhang X. Duan XC, et al. Among authors: feng zh. Int J Nanomedicine. 2018 Dec 24;14:195-204. doi: 10.2147/IJN.S186556. eCollection 2019. Int J Nanomedicine. 2018. PMID: 30636872 Free PMC article.

3

Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid.

Li ZY, Yin YF, Guo Y, Li H, Xu MQ, Liu M, Wang JR, Feng ZH, Duan XC, Zhang S, Zhang SQ, Wang GX, Liao A, Wang SM, Zhang X. Li ZY, et al. Among authors: feng zh. Int J Nanomedicine. 2020 Mar 16;15:1809-1821. doi: 10.2147/IJN.S240436. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32214813 Free PMC article.

4

The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death.

Duan XC, Peng LY, Yao X, Xu MQ, Li H, Zhang SQ, Li ZY, Wang JR, Feng ZH, Wang GX, Liao A, Chen Y, Zhang X. Duan XC, et al. Among authors: feng zh. Drug Deliv. 2021 Dec;28(1):800-813. doi: 10.1080/10717544.2021.1909180. Drug Deliv. 2021. PMID: 33866918 Free PMC article.

5

Effect of XlogP and hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles.

Xu MQ, Zhong T, Yao X, Li ZY, Li H, Wang JR, Feng ZH, Zhang X. Xu MQ, et al. Among authors: feng zh. Drug Deliv. 2021 Dec;28(1):1603-1615. doi: 10.1080/10717544.2021.1958107. Drug Deliv. 2021. PMID: 34319209 Free PMC article.

6

A combination strategy based on an Au nanorod/doxorubicin gel via mild photothermal therapy combined with antigen-capturing liposomes and anti-PD-L1 agent promote a positive shift in the cancer-immunity cycle.

Feng ZH, Li ZT, Zhang S, Wang JR, Li ZY, Xu MQ, Li H, Zhang SQ, Wang GX, Liao A, Zhang X. Feng ZH, et al. Acta Biomater. 2021 Dec;136:495-507. doi: 10.1016/j.actbio.2021.09.052. Epub 2021 Oct 5. Acta Biomater. 2021. PMID: 34619371

7

Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo.

Xu MQ, Hao YL, Wang JR, Li ZY, Li H, Feng ZH, Wang H, Wang JW, Zhang X. Xu MQ, et al. Among authors: feng zh. Int J Nanomedicine. 2021 Oct 27;16:7269-7281. doi: 10.2147/IJN.S331578. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34737564 Free PMC article.

8

Multifunctional ZnO@DOX/ICG-LMHP Nanoparticles for Synergistic Multimodal Antitumor Activity.

Li Z, Wang J, Liu J, Yu J, Wang J, Wang H, Wei Q, Liu M, Xu M, Feng Z, Zhong T, Zhang X. Li Z, et al. J Funct Biomater. 2024 Jan 30;15(2):35. doi: 10.3390/jfb15020035. J Funct Biomater. 2024. PMID: 38391888 Free PMC article.

9

Zinc oxide nanoparticles with catalase-like nanozyme activity and near-infrared light response: A combination of effective photodynamic therapy, autophagy, ferroptosis, and antitumor immunity.

Wang J, Liu M, Wang J, Li Z, Feng Z, Xu M, Wang H, Li H, Li Z, Yu J, Liu J, Wei Q, Zhang S, Zhang X. Wang J, et al. Acta Pharm Sin B. 2024 Oct;14(10):4493-4508. doi: 10.1016/j.apsb.2024.07.002. Epub 2024 Jul 5. Acta Pharm Sin B. 2024. PMID: 39525585 Free PMC article.

10

[A giant malignant melanoma of the palpebral conjunctiva: a case report].

Zhang XH, Yang Z, Lu Y, Feng ZH. Zhang XH, et al. Among authors: feng zh. Zhonghua Yan Ke Za Zhi. 2024 Mar 11;60(3):278-280. doi: 10.3760/cma.j.cn112142-20231110-00222. Zhonghua Yan Ke Za Zhi. 2024. PMID: 38462378 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters